| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract
|
Braybrooke, J.P.
|
|
|
8 |
3 |
p. 294-296
|
article
|
| 2 |
A phase II study of mitomycin C and oral etoposide for advancedadenocarcinoma of the upper gastrointestinal tract
|
J. P. Braybrooke
|
|
1997
|
8 |
3 |
p. 294-296
3 p.
|
article
|
| 3 |
Awards, appointments
|
|
|
|
8 |
3 |
p. 213
|
article
|
| 4 |
Bone marrow and peripheral blood stem cell transplantation in multiple myeloma
|
Gahrton, Gösta
|
|
|
8 |
3 |
p. 219-221
|
article
|
| 5 |
Bone marrow and peripheral blood stem cell transplantation in multiple myeloma
|
Gösta Gahrton
|
|
1997
|
8 |
3 |
p. 219-221
3 p.
|
article
|
| 6 |
Book review
|
Cavalli, F.
|
|
|
8 |
3 |
p. 214
|
article
|
| 7 |
Book review
|
Cerottini, J.-C.
|
|
|
8 |
3 |
p. 222
|
article
|
| 8 |
Bookreviews
|
J-C. Cerrotini
|
|
1997
|
8 |
3 |
p. 222-222
1 p.
|
article
|
| 9 |
Case history: A step up the analgesic ladder
|
M. Zenz
|
|
1997
|
8 |
3 |
p. 25-26
2 p.
|
article
|
| 10 |
Case history 2: The use of epoetin alfa before high-dosechemotherapy
|
R. Mertelsmann
|
|
1997
|
8 |
3 |
p. 13-13
1 p.
|
article
|
| 11 |
Case history 1: The use of epoetin alfa in delayed anaemia
|
R. Mertelsmann
|
|
1997
|
8 |
3 |
p. 11-12
2 p.
|
article
|
| 12 |
Cisplatin-paclitaxel weekly schedule in advanced solid tumors: A phase I study
|
Frasci, G.
|
|
|
8 |
3 |
p. 291-293
|
article
|
| 13 |
Cisplatinpaclitaxel weekly schedule in advanced solid tumors: A phase I study
|
G. Frasci
|
|
1997
|
8 |
3 |
p. 291-293
3 p.
|
article
|
| 14 |
Contents of the next issue
|
|
|
|
8 |
3 |
p. v
|
article
|
| 15 |
Copyright
|
|
|
|
8 |
3 |
p. iii
|
article
|
| 16 |
Current strategies for pain control
|
S. Ahmedzai
|
|
1997
|
8 |
3 |
p. 21-24
4 p.
|
article
|
| 17 |
Detection of occult gastric carcinoma with Indium-111 labeled CYT-103 (Oncoscint) immunoscintigraphy
|
Kruglyak, E.
|
|
|
8 |
3 |
p. 301-302
|
article
|
| 18 |
Detection of occult gastric carcinoma with Indium-111 labeled CYT-103 (Oncoscint) immunoscintigraphy
|
E. Kruglyak
|
|
1997
|
8 |
3 |
p. 301-302
2 p.
|
article
|
| 19 |
Eating to beat breast cancer: Potential role for soy supplements
|
Stoll, B.A.
|
|
|
8 |
3 |
p. 223-225
|
article
|
| 20 |
Eating to beat breast cancer: Potential role for soy supplements
|
B. A. Stoll
|
|
1997
|
8 |
3 |
p. 223-225
3 p.
|
article
|
| 21 |
Editorial Board
|
|
|
|
8 |
3 |
p. iv
|
article
|
| 22 |
Foreword
|
R. Mertelsmann
|
|
1997
|
8 |
3 |
p. 1-1
1 p.
|
article
|
| 23 |
Haematological toxicities associated with dose-intensive chemotherapy,the role for and use of recombinant growth factors
|
D. Henry
|
|
1997
|
8 |
3 |
p. 7-10
4 p.
|
article
|
| 24 |
High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma
|
Goldschmidt, H.
|
|
|
8 |
3 |
p. 243-246
|
article
|
| 25 |
High-dose therapy with peripheral blood progenitor cell transplantationin multiple myeloma
|
H. Goldschmidt
|
|
1997
|
8 |
3 |
p. 243-246
4 p.
|
article
|
| 26 |
5HT3 antagonists and radiotherapy
|
Mitchell, G.
|
|
|
8 |
3 |
p. 302
|
article
|
| 27 |
5HT_3 antagonists and radiotherapy
|
G. Mitchell
|
|
1997
|
8 |
3 |
p. 302-302
1 p.
|
article
|
| 28 |
Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: A randomised placebo-controlled trial
|
Beller, E.
|
|
|
8 |
3 |
p. 277-283
|
article
|
| 29 |
Improved quality of life with megestrol acetate in patients withendocrine-insensitive advanced cancer: A randomised placebo-controlledtrial
|
E. Beller
|
|
1997
|
8 |
3 |
p. 277-283
7 p.
|
article
|
| 30 |
In most of Central America access to oncology is still limited
|
|
|
|
8 |
3 |
p. 211-213
|
article
|
| 31 |
In this issue
|
|
|
|
8 |
3 |
p. v
|
article
|
| 32 |
Lymphadenopathy due to amyloid deposition in non-Hodgkin’s lymphoma
|
Simmonds, P.D.
|
|
|
8 |
3 |
p. 267-270
|
article
|
| 33 |
Lymphadenopathy due to amyloid deposition in non-Hodgkins lymphoma
|
P. D. Simmonds
|
|
1997
|
8 |
3 |
p. 267-270
4 p.
|
article
|
| 34 |
News
|
Steven Dickman
|
|
1997
|
8 |
3 |
p. 209-214
6 p.
|
article
|
| 35 |
PACE BOM chemotherapy: A 12-week regimen for advanced Hodgkin’s disease
|
Simmonds, P.D.
|
|
|
8 |
3 |
p. 259-266
|
article
|
| 36 |
PACE BOM chemotherapy: A 12-week regimen for advanced Hodgkinsdisease
|
P. D. Simmonds
|
|
1997
|
8 |
3 |
p. 259-266
8 p.
|
article
|
| 37 |
‘Patching’ embroyonic development to cancer
|
|
|
|
8 |
3 |
p. 209-214
|
article
|
| 38 |
Perhaps not everyone knows that…
|
|
|
|
8 |
3 |
p. 213-214
|
article
|
| 39 |
Post-remission therapy of adult acute myeloid leukaemia: One cycle of high-dose versus standard-dose cytarabine
|
Fopp, M.
|
|
|
8 |
3 |
p. 251-257
|
article
|
| 40 |
Post-remission therapy of adult acute myeloid leukaemia: One cycle ofhigh-dose versus standard-dose cytarabine
|
M. Fopp
|
|
1997
|
8 |
3 |
p. 251-257
7 p.
|
article
|
| 41 |
Quote/unquote
|
|
|
|
8 |
3 |
p. 213
|
article
|
| 42 |
Radiation therapy following breast conservation surgery: Can it ever be avoided?
|
Whelan, T.
|
|
|
8 |
3 |
p. 217-218
|
article
|
| 43 |
Radiation therapy following breast conservation surgery: Can it ever be avoided?
|
T. Whelan
|
|
1997
|
8 |
3 |
p. 217-218
2 p.
|
article
|
| 44 |
Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF
|
Fox, S.B.
|
|
|
8 |
3 |
p. 271-275
|
article
|
| 45 |
Relationship of elevated tumour thymidine phosphorylase in node-positivebreast carcinomas to the effects of adjuvant CMF
|
S. B. Fox
|
|
1997
|
8 |
3 |
p. 271-275
5 p.
|
article
|
| 46 |
Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy
|
Liljegren, G.
|
|
|
8 |
3 |
p. 235-241
|
article
|
| 47 |
Risk factors for local recurrence after conservative treatment in stageI breast cancer. Definition of a subgroup not requiring radiotherapy
|
G. Liljegren
|
|
1997
|
8 |
3 |
p. 235-241
7 p.
|
article
|
| 48 |
Risk of breast cancer subsequent to histological or clinical diagnosis of fibroadenoma - retrospective longitudinal study of 3938 cases
|
Ciatto, S.
|
|
|
8 |
3 |
p. 297-300
|
article
|
| 49 |
Risk of breast cancer subsequent to histological or clinical diagnosisof fibroadenoma retrospective longitudinal study of 3938 cases
|
S. Ciatto
|
|
1997
|
8 |
3 |
p. 297-300
4 p.
|
article
|
| 50 |
Table of Contents
|
|
|
|
8 |
3 |
p. ii-iii
|
article
|
| 51 |
The advancement of high-dose chemotherapy and dose intensificationschedules
|
R. C. F. Leonard
|
|
1997
|
8 |
3 |
p. 3-6
4 p.
|
article
|
| 52 |
Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literature
|
Reni, M.
|
|
|
8 |
3 |
p. 227-234
|
article
|
| 53 |
Therapeutic management of primary central nervous system lymphoma inimmunocompetent patients: Results of a critical review of the literature
|
M. Reni
|
|
1997
|
8 |
3 |
p. 227-234
8 p.
|
article
|
| 54 |
The systemic treatment of non-small-cell lung cancer
|
Propper, D.
|
|
|
8 |
3 |
p. 285-290
|
article
|
| 55 |
The systemic treatment of non-small-cell lung cancer
|
D. Propper
|
|
1997
|
8 |
3 |
p. 285-290
5 p.
|
article
|
| 56 |
The therapy of cancer pain and its integration into a comprehensivesupportive care strategy
|
M. Kjaer
|
|
1997
|
8 |
3 |
p. 15-19
5 p.
|
article
|
| 57 |
This letter was referred to the author, who responds as follows:
|
Aapro, M.S.
|
|
|
8 |
3 |
p. 302
|
article
|
| 58 |
This letter was referred to the author, who responds as follows:
|
M.S. Aapro
|
|
1997
|
8 |
3 |
p. 302-302
1 p.
|
article
|
| 59 |
Treatment of childhood Hodgkin’s disease with chemotherapy alone
|
Hudson, M.M.
|
|
|
8 |
3 |
p. 215-216
|
article
|
| 60 |
Treatment of childhood Hodgkins disease with chemotherapy alone
|
m.M. Hudson
|
|
1997
|
8 |
3 |
p. 215-216
2 p.
|
article
|
| 61 |
Treatment of childhood Hodgkin’s disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua
|
Baez, F.
|
|
|
8 |
3 |
p. 247-250
|
article
|
| 62 |
Treatment of childhood Hodgkins disease with COPP or COPP-ABV (hybrid)without radiotherapy in Nicaragua
|
F. Baez
|
|
1997
|
8 |
3 |
p. 247-250
4 p.
|
article
|
| 63 |
US panel fails to recommend mammography screening for women under the age of 50
|
|
|
|
8 |
3 |
p. 210-211
|
article
|
Journal description